wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38818496-05212C92-27FC-42AD-ADDF-2B255FA8F0CB
Q38818496-05212C92-27FC-42AD-ADDF-2B255FA8F0CB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38818496-05212C92-27FC-42AD-ADDF-2B255FA8F0CB
Caplacizumab reduces the frequency of major thromboembolic events, exacerbations and death in patients with acquired thrombotic thrombocytopenic purpura.
P2860
Q38818496-05212C92-27FC-42AD-ADDF-2B255FA8F0CB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38818496-05212C92-27FC-42AD-ADDF-2B255FA8F0CB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
dbdcd83a3dff08c66dbc4d67861a253e3bf0e7a2
P2860
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura.